C. V. van Helden-Meeuwsen

发表

The Kinetics of Plasmacytoid Dendritic Cell Accumulation in the Pancreas of the NOD Mouse during the Early Phases of Insulitis

H. Drexhage, M. Versnel, P. Leenen, 2013, PloS one.

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome

H. Drexhage, M. Versnel, J. P. Van de Merwe, 2013, Annals of the rheumatic diseases.

TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.

S. Kamphuis, M. Versnel, V. Dalm, 2018, Journal of autoimmunity.

Blood myxovirus resistance protein‐1 measurement in the diagnostic work‐up of suspected COVID‐19 infection in the emergency department

H. Endeman, W. Dik, M. Versnel, 2022, Immunity, inflammation and disease.

Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype

L. Joosten, S. Kamphuis, J. Tarn, 2022, Frontiers in Immunology.

Abnormalities of dendritic cell precursors in the pancreas of the NOD mouse model of diabetes

H. Drexhage, M. Versnel, J. Welzen-Coppens, 2012, European journal of immunology.

Hyposensitization in nickel allergic contact dermatitis: clinical and immunologic monitoring.

R. Benner, E. Prens, P. Mulder, 1995, Journal of the American Academy of Dermatology.

The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis

M. Vonk, W. B. van den Berg, T. Radstake, 2015, Annals of the rheumatic diseases.

Systemic increase in type I interferon activity in Sjögren's syndrome: A putative role for plasmacytoid dendritic cells

H. Drexhage, M. Versnel, J. P. Van de Merwe, 2008, European journal of immunology.

Eosinophils in the bronchial mucosa in relation to methacholine dose-response curves in atopic asthma.

H. Hoogsteden, J. Bogaard, G. M. Möller, 1999, Journal of applied physiology.

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression

H. Drexhage, W. Beumer, M. Versnel, 2012, Annals of the rheumatic diseases.

Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome

P. J. van der Spek, H. Drexhage, W. Beumer, 2016, Annals of the rheumatic diseases.

Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3‐Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon‐Positive Primary Sjögren's Syndrome

H. Drexhage, W. Dik, M. Versnel, 2016, Arthritis & rheumatology.

Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary Sjögren syndrome

A. Vissink, H. Drexhage, H. Bootsma, 2008, Annals of the rheumatic diseases.

Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren’s syndrome

H. V. D. van de Werken, W. Dik, M. Versnel, 2022, Rheumatology.

Detection of intestinal flora-derived bacterial antigen complexes in splenic macrophages of rats.

W. B. van den Berg, G. Bahr, L. van Lieshout, 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study

S. Kamphuis, P. H. Hissink Muller, E. Hoppenreijs, 2021, Rheumatology.

Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland

H. Drexhage, M. Versnel, M. Wildenberg, 2008, Arthritis research & therapy.

Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial

X. Mariette, J. Gottenberg, M. Versnel, 2019, Rheumatology.

Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets

P. J. van der Spek, M. Versnel, P. V. van Daele, 2019, Front. Immunol..

Detection of muramic acid in a carbohydrate fraction of human spleen

F. Eulderink, M. Melief, C. V. van Helden-Meeuwsen, 1995, Infection and immunity.

Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity

B. Griffiths, J. Tarn, D. Lendrem, 2018, Rheumatology.

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?

S. Kamphuis, M. Versnel, N. Maria, 2018, Arthritis Research & Therapy.

T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?

O. Corneth, M. Versnel, V. Dalm, 2014, Arthritis Research & Therapy.

Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren’s syndrome

W. Dik, M. Versnel, T. Mandl, 2021, Rheumatology.

Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study

S. Kamphuis, A. Langerak, M. Versnel, 2023, Lupus science & medicine.

NOD mice have a severly impaired ability to recruit leukocytes into sites of inflammation

H. Drexhage, S. Sozzani, M. Versnel, 2005, European journal of immunology.

The Gene Expression Profile of CD11c+CD8α− Dendritic Cells in the Pre-Diabetic Pancreas of the NOD Mouse

H. Drexhage, W. Beumer, M. Versnel, 2014, PloS one.

Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren’s syndrome patients through immunogenetics

A. Langerak, M. Versnel, P. V. van Daele, 2023, Frontiers in Oncology.

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy

C. Ruivenkamp, W. Dik, M. Versnel, 2019, Arthritis & rheumatology.